[巨细胞动脉炎治疗的挑战和前景]
Céline Schweri1, Michele Iudici1
1Service de rhumatologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|March 14, 2024
概括
早期诊断和治疗是巨细胞动脉炎 (GCA) 的关键. 目前的指导方针强调成像和标准治疗,如皮质类固醇和托西利祖马布,正在研究新的治疗方法.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 巨细胞动脉炎 (GCA) 需要早期诊断和治疗,以预防严重的并发症.
- 大血管血管炎的诊断和监测已经通过欧洲风湿病学协会联盟 (EULAR) 的成像建议得到了改进.
研究的目的:
- 总结目前巨细胞动脉炎的诊断和治疗策略.
- 突出成像在大血管血管炎管理中的作用.
- 讨论GCA的既定和新兴的治疗选择.
主要方法:
- 欧洲风湿病学协会联盟 (EULAR) 对大血管血管炎成像指南的审查.
- 对巨细胞动脉炎当前治疗标准的分析.
- 对新型皮质类固醇节约剂和治疗方案的正在进行的研究概述.
主要成果:
- 图像技术在诊断和监测GCA方面发挥着明确的作用.
- 皮质类固醇是主要的治疗方法,托西利祖马布作为首选的皮质类固醇节约剂.
- 目前正在研究新的治疗策略,包括"超轻"皮质类固醇治疗方案.
结论:
- 及时诊断和治疗对于管理GCA和避免并发症至关重要.
- 已建立的治疗方法包括皮质类固醇和托西利祖马布,以EULAR建议为指导.
- 未来的治疗选择有望改善GCA管理.
相关概念视频
Open Angle Glaucoma: Treatment
444
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
444
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
164
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
164
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
161
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
161
Angle Closure Glaucoma: Treatment
488
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
488
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
176
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
176


